Skip to main content

Table 3 Events of toxicity during chemo- and radiochemotherapy (* = phase I study)

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

  

Esophageal

Pulmonary

Hematologic

  

G1

G2

G3

G1

G2

G3

G1

G2

G3

Gemcitabine (mg/m2)

No.

3

19

7

18

6

5

12

9

1

300*

3

1

2

0

1

2

0

1

1

0

400*

3

1

2

0

1

2

0

1

2

0

500*

4

0

4

0

4

0

0

0

1

0

500

19

1

11

7

12

2

5

10

5

1